The Tat-Aβ1-6A2V(D) peptide against AD synaptopathy

Oncotarget. 2017 Feb 14;8(7):10773-10774. doi: 10.18632/oncotarget.14604.

Authors

Lucia Buccarello¹, Tiziana Borsello¹

Affiliation

¹ IRCCS -Istituto di Ricerche Farmacologiche "Mario Negri" and Department of Pharmacological and Biomolecular Sciences, University of Milan, Milan, Italy.

No abstract available

Keywords: Neuroscience; cell permeable peptide; neurodegenerative diseases; neuroprotection; synaptic dysfunction.

Publication types

Editorial

MeSH terms

Alzheimer Disease / metabolism*
Amyloid beta-Peptides / chemistry*
Animals
Brain / metabolism
Cognitive Dysfunction / metabolism
Disks Large Homolog 4 Protein / metabolism
Humans
Mutation
Peptide Fragments
Phosphorylation
Protein Denaturation
Protein Folding
Receptors, AMPA / metabolism
Receptors, N-Methyl-D-Aspartate / metabolism
Synapses / metabolism*
Synucleins / metabolism
tau Proteins / chemistry

Substances

Amyloid beta-Peptides
DLG4 protein, human
Disks Large Homolog 4 Protein
Peptide Fragments
Receptors, AMPA
Receptors, N-Methyl-D-Aspartate
Synucleins
tau Proteins